Daily Equity Reports 17 June 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 17 THJUNE 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 39741.36 INDIAN EQUITY BENCHMARK - Sharp fall in late trading pulled the indices to the low of the day on June 14 with Nifty ended below 11,850 level. At close, the Sensex was down NIFTY 11914.05 289.29 points at 39,452.07, while Nifty was down 90.70 CLOSE PREVIOUS points at 11,823.30. About 808 shares have advanced, 1686 NIKKEI 21032.00 shares declined, and 144 shares are unchanged. IndusInd Bank, Zee Entertainment, Indiabulls Housing, Bharti Airtel 27294.71 and Axis Bank were the top losers on the Nifty, while gainers 2095.41 were Bharti Infratel, Sun Pharma, Power Grid, L&T and SECTORIAL INDICES Vedanta. All the sectoral indices ended lower led by FMCG, CLOSE CHANGE (%) bank, auto, pharma, infra, metal, IT and energy. GLOBAL FACE CNX 100 11899.35 S&P CNX 500 ! Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.40%, while the Shanghai Composite led the Hang Seng lower. They fell 0.99% CNX 200 BANK NIFTY 30614.35 and 0.65% respectively. TOP GAINERS ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The Bovespa CLOSE CHANGE (%) gained 0.46% and the S&P 500 rose 0.41%. The IPC lost 0.72%. SUNPHARMA ! European markets – European markets are lower today with shares in Germany off the most. The DAX is down 0.69% while London's FTSE 100 is off 0.46% and France's CAC 40 is lower by 0.32%. TOP LOSERS CLOSE CHANGE (%) INDUSINDBK BHARTIARTL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 1.53 INFRATEL 275.50 PIVOT POINTS 0.28 S3 11615 S2 11730 R1 11890 R2 11958 R3 12072 ADANIPORT 426.15 11776 11844 0.20 WIPRO 299.00 S1-11700 S2-11565 R1-11990 R2-12100 0.18 VEDL 168.75 MARKET MOVERS DOWNSIDE CLOSE (%) -4.59 INDUSINDBK -2.54 -2.30 -2.21 KOTAKBANK NET BUY (CR.) NET SELL (CR) STRATEGY SELL ON RISE 5023.52 PIVOT POINTS P 30709 S1 30376 R1 30915 R2 R3 31786 DII 2241.17 29631 30170 31248 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS Hexaware acquires 100% shares of! Mobiquity Softech Hexaware, in its filing to the exchanges on Friday, informed that the company has acquired 100% stakes of Mobiquity Softech Private Limited, a wholly owned subsidiary of Mobiquity Inc for a total consideration of ~ $182mn. This acquisition would help gain traction in banking and Pharma verticals, which are the focus areas for Hexaware. It also brings in valued partnerships particularly with A WS and Backbase, the company said in a press note. RBI to inject durable liquidity through OMO purchase auction The Reserve Bank of India said on Thursday that it will infuse Rs12,500cr into the financial system through bond purchases on June 20. Based on a review of the evolving liquidity conditions and assessment of the durable liquidity needs going forward, RBI has decided to conduct the purchase of Government securities under Open Market Operation (OMO) for Rs12500cr on June 20, 2019, the RBI said in the press note. The Government securities to be purchased in the auction would be communicated in due course, the central bank said. ! USFDA completes inspection at Wockhardt's Bioequivalence centre in Aurangabad Wockhardt said it has received zero observations from the US health regulator (USFDA) after inspection of its Bioequivalence centre at Aurangabad in Maharashtra. The announcement was made on Thursday after market hours. The United States Food and Drug Administration carried out an inspection of the Bioequivalence centre located at the R&D centre, Aurangabad from June 10 to June 12, 2019, the pharma company said the filing. During the inspection, bioanalytical and quality systems ! of Bioequivalence studies of Tamsulosin 0.4 mg capsules ! Tata Sponges board approves date for right issues Tata Sponge, in its filing to the exchanges informed that its board has granted approval of the issuance of equity shares by way of rights issue to the existing shareholders of the company as on the record date for an amount not exceeding Rs1, 800 cr and fixed record date for rights issue at June 25. The companys board has given approval for issuance of 3.3cr equity shares of the face value of Rs10 each, on a rights basis, not exceeding an amount of Rs1,650cr by the company to the eligible equity shareholders, the company said in a press note to the exchanges. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : HDFCAMC DATE : 17/06/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY HDFCAMC IN CASH ABOVE 1937 TGT 1977 SL 1900 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.